Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

2.

Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).

Tanaka K, Yamaguchi S, Sawano A, Shibuya M.

Jpn J Cancer Res. 1997 Sep;88(9):867-76.

PMID:
9369935
3.
4.

The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma.

Sawano A, Takahashi T, Yamaguchi S, Shibuya M.

Biochem Biophys Res Commun. 1997 Sep 18;238(2):487-91.

PMID:
9299537
6.

Mechanisms of angiogenesis.

Risau W.

Nature. 1997 Apr 17;386(6626):671-4. Review.

PMID:
9109485
7.

Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.

Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G, Marmé D, Martiny-Baron G.

J Biol Chem. 1997 Apr 18;272(16):10382-8.

8.

Oncoprotein networks.

Hunter T.

Cell. 1997 Feb 7;88(3):333-46. Review. No abstract available.

9.

The biology of vascular endothelial growth factor.

Ferrara N, Davis-Smyth T.

Endocr Rev. 1997 Feb;18(1):4-25. Review. No abstract available.

PMID:
9034784
10.

Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development.

Maina F, Casagranda F, Audero E, Simeone A, Comoglio PM, Klein R, Ponzetto C.

Cell. 1996 Nov 1;87(3):531-42.

11.

Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M.

Cell Growth Differ. 1996 Feb;7(2):213-21.

12.

Nuk controls pathfinding of commissural axons in the mammalian central nervous system.

Henkemeyer M, Orioli D, Henderson JT, Saxton TM, Roder J, Pawson T, Klein R.

Cell. 1996 Jul 12;86(1):35-46.

13.
14.

The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo.

DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinetz E, Compton DL, Rojas E, Park JS, Smith C, DiStefano PS, Glass DJ, Burden SJ, Yancopoulos GD.

Cell. 1996 May 17;85(4):501-12.

15.

Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marmé D.

Blood. 1996 Apr 15;87(8):3336-43.

16.

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW.

Nature. 1996 Apr 4;380(6573):439-42.

17.

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A.

Nature. 1996 Apr 4;380(6573):435-9.

PMID:
8602241
18.

Role of VEGF-flt receptor system in normal and tumor angiogenesis.

Shibuya M.

Adv Cancer Res. 1995;67:281-316. Review. No abstract available.

PMID:
8571818
19.

Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor.

Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, Minowa O, Kuno J, Sakakibara S, Yamada M, Yoneshima H, Miyawaki A, Fukuuchi Y, Furuichi T, Okano H, Mikoshiba K, Noda T.

Nature. 1996 Jan 11;379(6561):168-71.

PMID:
8538767
20.

Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development.

Eichmann A, Marcelle C, Bréant C, Le Douarin NM.

Mech Dev. 1993 Jul;42(1-2):33-48.

PMID:
8396413

Supplemental Content

Support Center